Data gathered: December 24
Alternative Data for Chromadex
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 4 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | N/A | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | 13 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,967 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,154 | Sign up | Sign up | Sign up |
| Twitter Followers | 3,290 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 74 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 35 | Sign up | Sign up | Sign up |
| Linkedin Employees | 130 | Sign up | Sign up | Sign up |
About Chromadex
ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services.
| Price | $5.44 |
| Target Price | Sign up |
| Volume | 196,030 |
| Market Cap | $405M |
| Year Range | $2.44 - $7.72 |
| Dividend Yield | 0% |
| PE Ratio | 265 |
| Analyst Rating | 100% buy |
| Industry | Fitness & Health |
In the news
 |
ChromaDex (NASDAQ:CDXC) Downgraded to “Buy” Rating by StockNews.comDecember 19 - ETF Daily News |
 |
ChromaDex (NASDAQ:CDXC) Upgraded at StockNews.comDecember 10 - ETF Daily News |
 |
Even though ChromaDex (NASDAQ:CDXC) has lost US$73m market cap in last 7 days, shareholders are still up 389% over 1 yearDecember 9 - Yahoo |
|
ChromaDex (NASDAQ:CDXC) Shares Gap Up – What’s Next?December 7 - ETF Daily News |
 |
ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run?November 21 - Yahoo |
Clinical Chemistry Pipeline Report Featuring Almost 200 Companies/Universities by Stages of Development, Segments, Region and Countries, Regulatory PathDecember 20 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 26M | 9.3M | 16M | 1.9M | 1.6M | 0.020 |
| Q2 '24 | 23M | 9M | 14M | -15,000 | -220,000 | 0.000 |
| Q1 '24 | 22M | 8.7M | 13M | -500,000 | -690,000 | -0.010 |
| Q4 '23 | 21M | 8.3M | 13M | 160,000 | -130,000 | 0.002 |
| Q3 '23 | 19M | 7.5M | 12M | -960,000 | -1.1M | -0.010 |
Insider Transactions View All
| Jaksch Frank L Jr filed to sell 244,179 shares at $6.2. December 13 '24 |
| Pamir Ozan filed to buy 2,907 shares at $7.4. November 25 '24 |
| Dvorak International Ltd filed to buy 19,294,356 shares at $0. August 21 '24 |
Similar companies
Read more about Chromadex (CDXC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Chromadex?
The Market Cap of Chromadex is $405M.
What is Chromadex's PE Ratio?
As of today, Chromadex's PE (Price to Earnings) ratio is 265.
What is the current stock price of Chromadex?
Currently, the price of one share of Chromadex stock is $5.44.
How can I analyze the CDXC stock price chart for investment decisions?
The CDXC stock price chart above provides a comprehensive visual representation of Chromadex's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Chromadex shares. Our platform offers an up-to-date CDXC stock price chart, along with technical data analysis and alternative data insights.
Does CDXC offer dividends to its shareholders?
As of our latest update, Chromadex (CDXC) does not offer dividends to its shareholders. Investors interested in Chromadex should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Chromadex?
Some of the similar stocks of Chromadex are Peloton, Planet Fitness, WW International, Academy Sports + Outdoors, and Herbalife Nutrition.
.